Navigation Links
CardioGenics Holdings Inc. Provides Update on FINRA Submission Regarding Name Change
Date:10/14/2009

MISSISSAUGA, Ontario, Oct. 14 /PRNewswire-FirstCall/ -- CardioGenics Holdings Inc. (OTC Bulletin Board: JAGH), provides an update on its submission to FINRA regarding the change in the company's name, ticker symbol and CUSIP number.

The company has submitted to FINRA all documentation requested in connection with the name change, and the related changes of the ticker symbol and CUSIP number for the company's common shares. FINRA is working through its internal implementation process, and until such changes are implemented by FINRA, the company's common shares will continue to trade under its current symbol, JAGH.

About CardioGenics Holdings Inc.

CardioGenics Holdings Inc. develops technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. It has developed the QL Care Analyzer, a proprietary Point Of Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's principal offices are located in Mississauga, Ontario, Canada.

Safe Harbor Statement - Certain statements made herein that are not historical are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995 and may contain forward-looking statements, with words such as "Anticipate, "believe," "expect," "future," "may," "will," "should," "plan," "projected," "intend," and similar expressions to identify forward-looking statements. These statements are based on the Company's beliefs and the assumptions it made using information currently available to it. Because these statements reflect the Company's current views concerning future events, these statements involve risks, uncertainties and assumptions. The actual results could differ materially from the results discussed in the forward-looking statements. In any event, undue reliance should not be placed on any forward-looking statements, which apply only as of the date of this press release. Accordingly, reference should be made to the Company's periodic filings with the Securities and Exchange Commission.

SOURCE CardioGenics Holdings Inc.


'/>"/>
SOURCE CardioGenics Holdings Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
2. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
3. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
4. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
5. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
6. Lincare Holdings Inc. Extends Terms of Employment Agreements with Executive Officers
7. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
8. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
9. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
10. Raptor Pharmaceuticals Provides Update of Product Programs
11. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 7, 2016  Organovo Holdings, Inc. (NASDAQ: ... focused on delivering scientific and medical breakthroughs using ... and Chief Executive Officer Keith Murphy ... December 14, 2016 at 1:00 p.m. Eastern Time ... yet familiar with the Company, an informational video ...
(Date:12/7/2016)... NEW YORK , December 7, 2016 ... by Persistence Market Research titled , Global Market Study on ... Market Through 2024 , the global multiplex detection immunoassay ... the forecast period 2016-2024. ... , , ...
(Date:12/6/2016)... 6, 2016  Licenders is bringing their 100% all-natural lice removal ... Park Slope at 203 13 th Street was specifically chosen ... clientele. "Our goal is to ease parents, stress and ... to get children right back to class without skipping a beat. ... and safe for the whole family," Licenders President Adie Horowitz ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... Augustine ... services to families and business owners in the greater Dallas metropolitan area, is ... Dallas Fallen Officer Foundation. , Established in 2009 by active police professionals in ...
(Date:12/7/2016)... Peoria, IL (PRWEB) , ... December 07, 2016 , ... ... holiday season. Many children are not fortunate enough to receive bountiful gifts wrapped ... that unwrapping presents can bring to the children of the world. , In exchange ...
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 , ... ... new study entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” ... The study was published in the prestigious Journal of Veterinary Science & Medical ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... announce that its fully redesigned website, which launched October 17, 2016, features comprehensive ... responsive design and easy-to-navigate layout. Visitors and patients can discover the latest clinical ...
(Date:12/7/2016)... , ... December 07, 2016 , ... Delete® - Tattoo ... Time For The Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® ... is providing the Phoenix Valley with Delightful Deals on Botox® and Juvederm® ...
Breaking Medicine News(10 mins):